Characteristics of cases with hospitalisation due to varicella zoster virus infection in BIOBADASER 2.0
| Gender/Age | Diagnosis | Disease duration (years) | Treatment | Treatment duration (years) | Treatment discontinuation | MTX | Steroids | Infection | Extension |
|---|---|---|---|---|---|---|---|---|---|
| M/32 | AS | – | Infliximab | 0.41 | Yes | Yes | No | Chickenpox | Pneumonia |
| M/32 | AS | 8.1 | Etanercept | 0.99 | Yes | No | No | Chickenpox | Skin only |
| F/34 | PsA | 6.2 | Etanercept | 1.32 | Yes | No | Yes | Chickenpox | Otitis with tympanic membrane perforation |
| F/37 | SCP | 1.9 | Infliximab | 1.01 | Yes | Yes | Yes | Chickenpox | Pneumonia |
| F/52 | RA | 7.2 | Adalimumab | 2.11 | No | No | Yes | Shingles | Localised |
| F/56 | AS | 24.8 | Infliximab | 2.77 | No | No | No | Shingles | Localised |
| F/61 | RA | 6.3 | Etanercept | 5.66 | Yes | Yes | No | Shingles | Localised |
| M/73 | RA | 6.4 | Infliximab | 0.69 | No | Yes | Yes | Shingles | Localised |
| F/74 | RA | 3.2 | Etanercept | 0.76 | No | No | Yes | Shingles | Localised |
AS, ankylosing spondylitis; BIOBADASER, Registro Español de Acontecimientos Adversos de Terapias Biológicas en Enfermedades Reumáticas; MTX, methotrexate; PsA, psoriatic arthritis; RA, rheumatoid arthritis; SCP, seronegative chronic polyarthritis.